Circulating Tumor Cell Assessment in Presumed Early Stage Non-small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study

In patients treated with SBRT for presumed early stage non-small cell lung cancer (NSCLC), detection and monitoring of circulating tumor cells (CTCs) may be useful for assessing treatment response safely and non-invasively. No published reports of CTC trends in this patient population exist to date.

https://ift.tt/2KCuqrv